HBIO vs A
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 20, 2026
HBIO
A
Investment Advisor Scores
A
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HBIO | A | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.0602 | 23.8663 | HBIO |
| PEG Ratio | 1.3059 | 1.3652 | HBIO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.1% | 8.1% | HBIO |
| Earnings Growth | -80.3% | 8.5% | A |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.1/100 | 42.1/100 | HBIO |
| Profit Margin | -11.9% | 19.5% | A |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HBIO
MarkupPrice above SMA50, rising 50-day trend (11.7% over 20 days), RSI 62
A
MarkupPrice above SMA50, rising 50-day trend (8.8% over 20 days), RSI 62
Fundamentals Snapshot
| Metric | HBIO | A |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.2 | 26.3 |
| Trailing P/E | — | 34.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.6% | 0.5% |
| Operating Margin | 0.0% | 0.3% |
| EPS | -2.31 | 5.07 |
| Dividend Yield | — | 0.01% |